African Horse Sickness Virus AHSV-VP7 antibody and antigen (recombinant protein)

 Download 

Diagnostic anti-African Horse Sickness Virus AHSV-VP7 antibodies pairs and antigen for animal health (animal Equine/Horse, Mule, Donkey infectious disease African horse sickness) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Go to Equine/Horse disease testing products collection >>

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-VT-P140-Tg001-Ag01	Recombinant African Horse Sickness Virus AHSV-VP7 protein	$3090.00
GMP-VT-P140-Tg001-Ab01	Anti-African Horse Sickness Virus AHSV-VP7 mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P140-Tg001-Ab02	Anti-African Horse Sickness Virus AHSV-VP7 mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P140-Tg001-Ab03	Anti-African Horse Sickness Virus AHSV-VP7 human monoclonal antibody (mAb)	$3090.00
GMP-VT-P140-Tg001-Ab04	Anti-African Horse Sickness Virus AHSV-VP7 human monoclonal antibody (mAb)	$3090.00

Size： 1mg | 10mg | 100mg

Product Description

Cat No.	GMP-VT-P140-Tg001-Ag01
Product Name	Recombinant African Horse Sickness Virus AHSV-VP7 protein
Pathogen	African Horse Sickness Virus
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-African Horse Sickness Virus AHSV-VP7 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in African Horse Sickness Virus level test of animal Equine/Horse, Mule, Donkey infectious disease with African horse sickness.
Tag	His
Product description	Recombinant African Horse Sickness Virus AHSV-VP7 proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P140-Tg001-Ab01,GMP-VT-P140-Tg001-Ab02
Pathogen	African Horse Sickness Virus
Product Name	Anti-African Horse Sickness Virus AHSV-VP7 mouse monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant African Horse Sickness Virus AHSV-VP7 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-African Horse Sickness Virus antibodies in African Horse Sickness Virus level test of animal Equine/Horse, Mule, Donkey infectious disease with African horse sickness.
Product description	Anti-African Horse Sickness Virus AHSV-VP7 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-African Horse Sickness Virus antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P140-Tg001-Ab03,GMP-VT-P140-Tg001-Ab04
Pathogen	African Horse Sickness Virus
Product Name	Anti-African Horse Sickness Virus AHSV-VP7 human monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Human lgG1
Bioactivity validation	Recombinant African Horse Sickness Virus AHSV-VP7 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-African Horse Sickness Virus antibodies in African Horse Sickness Virus level test of animal Equine/Horse, Mule, Donkey infectious disease with African horse sickness.
Product description	Anti-African Horse Sickness Virus AHSV-VP7 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Pathogen Information

Canine Parainfluenza 2 Virus is transmitted through infected respiratory secretions, such as nasal discharge, saliva, and coughing, from one dog to another. The virus can also spread indirectly through contact with contaminated objects, such as food and water bowls, toys, and clothing. Therefore, it is important to isolate infected dogs and disinfect their living areas to prevent the spread of the virus.

Infection with Canine Parainfluenza 2 Virus typically starts with an incubation period of two to five days, during which the virus replicates in the respiratory tract. Symptoms of the disease usually appear after the incubation period and can range from mild to severe, depending on the health and age of the dog. Common symptoms include coughing, sneezing, nasal discharge, fever, lethargy, and loss of appetite. In severe cases, the virus can cause pneumonia, which can be life-threatening, especially in young puppies and older dogs.

Treatment for Canine Parainfluenza 2 Virus is primarily supportive and focuses on relieving clinical signs and preventing secondary bacterial infections. Antibiotics may be prescribed if secondary bacterial infections develop. In addition, antitussive agents, bronchodilators, and other supportive therapies may be used to manage respiratory symptoms. Vaccination is the most effective way to prevent infection with Canine Parainfluenza 2 Virus and is recommended for all dogs, especially those at higher risk of exposure, such as puppies, shelter dogs, and dogs in kennels.

In summary, Canine Parainfluenza 2 Virus is a highly contagious respiratory virus that primarily affects dogs, particularly puppies. Its nucleoprotein gene is the main gene of the virus, which encodes its nucleoprotein, and it contains several surface proteins, including the fusion protein and hemagglutinin-neuraminidase protein. Diagnostic methods for Canine Parainfluenza 2 Virus include immunofluorescence assays, ELISA tests, and PCR-based tests. Treatment for the virus is mainly supportive, and vaccination is the best way to prevent infection. It is essential to isolate infected dogs and disinfect their living areas to prevent the spread of the virus, as well as to seek timely veterinary care if symptoms develop.

About GDU